Moghtaderi, Mozhgan, Nabavizadeh, Seyed Hesamedin, Moazzen, Nasrin, Samadzadeh Mamaghani, mohammadreza, Mostafavi, Sara, Mostafavi, Ali. (1402). A Comparison of Efficacy and Adverse Effects of Cetirizine and Desloratadine in 6-12-Year-Old Children with Allergic Rhinitis. , 11(4), 17583-17589. doi: 10.22038/ijp.2023.70914.5212
Mozhgan Moghtaderi; Seyed Hesamedin Nabavizadeh; Nasrin Moazzen; mohammadreza Samadzadeh Mamaghani; Sara Mostafavi; Ali Mostafavi. "A Comparison of Efficacy and Adverse Effects of Cetirizine and Desloratadine in 6-12-Year-Old Children with Allergic Rhinitis". , 11, 4, 1402, 17583-17589. doi: 10.22038/ijp.2023.70914.5212
Moghtaderi, Mozhgan, Nabavizadeh, Seyed Hesamedin, Moazzen, Nasrin, Samadzadeh Mamaghani, mohammadreza, Mostafavi, Sara, Mostafavi, Ali. (1402). 'A Comparison of Efficacy and Adverse Effects of Cetirizine and Desloratadine in 6-12-Year-Old Children with Allergic Rhinitis', , 11(4), pp. 17583-17589. doi: 10.22038/ijp.2023.70914.5212
Moghtaderi, Mozhgan, Nabavizadeh, Seyed Hesamedin, Moazzen, Nasrin, Samadzadeh Mamaghani, mohammadreza, Mostafavi, Sara, Mostafavi, Ali. A Comparison of Efficacy and Adverse Effects of Cetirizine and Desloratadine in 6-12-Year-Old Children with Allergic Rhinitis. , 1402; 11(4): 17583-17589. doi: 10.22038/ijp.2023.70914.5212

A Comparison of Efficacy and Adverse Effects of Cetirizine and Desloratadine in 6-12-Year-Old Children with Allergic Rhinitis

Journal of Pediatric Perspectives
مقاله 4، دوره 11، شماره 4، تیر 2023، صفحه 17583-17589    اصل مقاله (282.32 K)
نوع مقاله: original article
شناسه دیجیتال (DOI): 10.22038/ijp.2023.70914.5212
نویسندگان
Mozhgan Moghtaderi1؛ Seyed Hesamedin Nabavizadeh2؛ Nasrin Moazzen3؛ mohammadreza Samadzadeh Mamaghani4؛ Sara Mostafavi* 5؛ Ali Mostafavi6
1Neonatal Research Center, Shiraz University of Medical Science, Shiraz, Iran
2Department of Pediatrics, Shiraz University of Medical Science, Shiraz, Iran
3Allergy Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
4Department of pharmacology, Faculty of Veterinary Medicine, University of Tehran, Iran
5Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
6University of Arizona, Tucson, AZ 85721, USA
چکیده
Background: Antihistamines are the most common drugs used for treating allergic rhinitis. They, significantly, reduce nasal symptoms by blocking the action of a chemical cytokine called histamine.  This study aimed to compare cetirizine and desloratadine's efficacy and adverse effects in children with allergic rhinitis.
Method: This randomized single-blinded clinical trial was conducted on 400 children with allergic rhinitis, aged 6-12 between February and September 2022. The patients were randomized to receive cetirizine or desloratadine for four weeks. We recorded the symptoms and adverse effects at the baseline and four weeks after starting the intervention.
Results: A total of 248 patients completed the study: 109 patients (47 female, 62 male) in the cetirizine group and 139 patients (53 female, 86 male) in the desloratadine group. The scores related to symptoms of allergic rhinitis before starting the drugs and after 4-week therapy were not significantly different between the two treatment groups (p= 0.1, p= 0.7, respectively). Cetirizine had more side effects than desloratadine in the treated patients (p = 0.02).
Conclusion: This study showed that cetirizine and desloratadine improved symptoms of children with allergic rhinitis; however, there was no significant difference in the efficacy of these two drugs.  Desloratadine caused fewer side effects in patients after 4 weeks of treatment.
کلیدواژه‌ها
Cetirizine,,؛ ,،Desloratadine,,؛ ,،Allergic rhinitis,,؛ ,،Histamine antagonists
مراجع
آمار
تعداد مشاهده مقاله: 5,734
تعداد دریافت فایل اصل مقاله: 6,733
دانشگاه علوم پزشکی مشهد
آمار
تعداد نشریات29
تعداد شماره‌ها2,321
تعداد مقالات24,818
تعداد مشاهده مقاله82,372,739
تعداد دریافت فایل اصل مقاله45,575,643